期刊文献+

左西孟旦对高血压患者心率变异性的影响

Effect of levosimendan on heart rate variability in patients with hypertension
下载PDF
导出
摘要 目的探讨左西孟旦对高血压患者心率变异性(HRV)的影响。方法选取本院治疗的57例高血压患者作为研究对象,所有患者均给予左西孟旦静脉滴注,患者治疗前2周及治疗6周后接受Holter记录,分析治疗前后患者HRV变化情况。结果治疗后患者正常R-R间期标准差(SDNN)、相邻R-R间期标准差(RMSSD)以及相邻R-R间期大于50ms的百分比(PNN50)均明显高于治疗前,与治疗前相比差异有统计学意义(P<0.05);高频(HF)较治疗前显著上升(P<0.05),而LF/HF较治疗前明显下降(P<0.05)。结论左西孟旦能有效地改善高血压患者HRV,临床上治疗高血压可以使患者更多的收益。 Objective To investigate the effects of levosimendan on heart rate variability (HRV) in patients with hypertension .Methods 57 hypertension patients were enrolled and treated with intravenous infusion of levosi-mendan .Holter recordings was performed and changes of HRV ,2 weeks before and 6 weeks after treatment ,were analyzed .Results After treatment ,standard deviation of normal R-R intervals (SDNN) ,root mean squared succes-sive difference (Rmssd) and percent of NN50 in the total number R-R intervals (PNN50) were significantly higher than before treatment (t=2 .020 ,4 .800 ,2 .755 ,P〈0 .05) .High-frequency (HF) increased significantly after treat-ment (t=4 .074 ,P〈0 .05) and low-frequency(LF)/HF ratio decreased significantly (t=4 .267 ,P〈0 .05) .Conclu-sion Levosimendan could effectively improve HRV in patients with hypertension and could be used for the treatment of hypertension ..
作者 廉永刚
出处 《检验医学与临床》 CAS 2013年第17期2279-2280,共2页 Laboratory Medicine and Clinic
关键词 左西孟旦 高血压 心率变异性 levosimendan hypertension heart rate variability
  • 相关文献

参考文献7

二级参考文献25

  • 1Rognoni A,Lupi A,Lazzero M,et al.Levosimendan:from basic science to clinical trials. Recent Pat Cardiovasc Drug Discov,2011,6:9-15.
  • 2Mebazaa A,Nieminen M,Packer M,et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure:the SURVIVE randomized trial.JAMA,2007,297:1883-1891.
  • 3Krell MJ,Kline EM,Bates ER,et al.Intermittent,ambulatory dobutamine infusion in severe heart failure.Am Heart J,1986,112:787-791.
  • 4Moiseyev VS,Poder P,Andrejevs N,et al.Safety and efficacy of a novel calcium sensitizer,levosimendan in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN).Eur Heart J,2002,23:1422-1432.
  • 5Follath F,Cleland JG,Just H,et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe lowoutput heart failure (the LIDO study):a randomised double-blind trial.Lancet,2002,360:196-202.
  • 6Parissis JT, Paraskevaidis I, Bistola V, et al. Effects of levosimendan on right ventricular function in patients with advanced heart failure.Am J Cardiol,2006,98:1489-1492.
  • 7Bergh CH, Andersson B, Dahlstr(o)m U, et al. Intravenous levosimendan vs dobutamine in acute decompensated heart failure patients on beta-blockers. Eur J Heart Failure,2010,12:404-410.
  • 8Nieminen MS, Akkila J, Hasenfuss G. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.J Am Coil Cardiol,2000,36:1903-1912.
  • 9Izzedine H,Lannay-VacherV,Deray G.Abnormal blood pressurecircadian rhythm:a target organ damage[J].Int J Cardial,2006,107(3):343-349.
  • 10Moller DS,Lind P,Strange B,et al.Abnormal vasoactive hormonesand 24-hour blood pressure in obstructive sleep apnea[J].Am JHypertens,2003,16(4):274-280.

共引文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部